Month: September 2021

With reference to the stock notice of 12 June 2020 AKVA group ASA (“AKVA”) hereby announce that the company has been awarded the contract for the full grow-out RAS project from the Norwegian company AquaCon AS. AquaCon AS is planning to build a new land based grow-out facility on Eastern Shore, Maryland, USA. The value of AKVA’s delivery is estimated to be USD 150 million for the first phase (16,000 tonnes). AKVA and Israel Corp. will jointly participate in a USD 5 million convertible loan, and have the option to invest additional USD 15 million, both under certain conditions.Dated: 29 September 2021AKVA group ASA Web: www.akvagroup.com CONTACTS:Knut Nesse Chief Executive OfficerPhone: +47 51 77 85 00Mobile: +47 91 37 62 20E-mail: knesse@akvagroup.comRonny Meinkøhn Chief Financial OfficerPhone: +47 51 77 85 00Mobile: +47...

Israel Corp., a listed Israeli investment company that owns and invests in high quality companies with established managements and go-to markets, will take an appr. 15% stake in AKVA group ASA (“AKVA”), and partner with AKVA in attracting investments for land-based projects based on AKVA solutions and technology. Egersund Group AS will still hold the majority ownership in AKVA. AKVA has today entered into an agreement with Israel Corp. (TASE: ILCO) that will result in Israel Corp. taking a 15% ownership stake in AKVA. The investment will be completed through (i) a private placement of 3,333,430 newly issued shares (corresponding to appr. 10% of the current outstanding shares in AKVA) at a subscription price of NOK 96.50 per share and an aggregate amount of NOK 321.7 million, and (ii) purchases of minimum 2,166,730 shares from...

OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE 29 SEPTEMBER 2021 AT 8.31 A.M., CHANGES IN THE COMPANY’S OWN SHARESOma Savings Bank Plc will carry out a direct share issue to Eurajoen Savings Bank On 23 September 2021, Oma Savings Bank (OmaSp or the company) announced the Board’s decision to carry out a paid directed share issue to Eurajoen Savings Bank. The decision was conditional and its entry into force required a decision made by the governing body of Eurajoen Savings Bank to transfer the business to OmaSp in accordance with the acquisition plan registered in June 2021. At its meeting on 28 September 2021, the governing body of Eurajoen Savings Bank decided to transfer the business of Eurajoen Savings Bank to OmaSp and therefore the decision of OmaSp’s Board of Directors on the directed share issue to Eurajoen Savings Bank has...

Geneva, Switzerland, September 29, 2021 – Addex Therapeutics (SIX: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that CEO, Tim Dyer, will present at the Cantor Global Healthcare 2021 Conference (September 27 – 30, 2021). In his presentation, which is scheduled for Wednesday, September 29, 2021 at 08:00 EDT / 14:00 CEST, Mr Dyer will provide a corporate update and discuss recent developments at Addex. The video presentation will be available for viewing on-demand by registered participants from the time of the presentation and subsequently on the Events page of the Company’s website (https://www.addextherapeutics.com/en/investors/events/). The video replay will be archived for 90 days following the event. Management will be available for...

Type of dystonia characterized by involuntary spasms of the eyelid muscles can lead to substantial visual disturbance or functional blindness Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, September 29, 2021 – Addex Therapeutics Ltd (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today the initiation of a Phase 2a clinical study with dipraglurant as a potential treatment for blepharospasm, a type of dystonia characterized by involuntary contractions or spasms of the eyelid muscles resulting in sustained eyelid closure, which can result in substantial visual disturbance or functional blindness. Dipraglurant selectively targets the metabotropic glutamate receptor subtype 5 (mGlu5) to downregulate neurotransmission through...

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Cambridge, UK and Indianapolis, US – 29 September 2021: Acacia Pharma Group plc (“Acacia Pharma” or the “Company”) (EURONEXT: ACPH), a commercial stage biopharmaceutical company focused on developing and commercializing novel products to improve the care of patients undergoing serious medical treatments such as surgery, invasive procedures, or cancer chemotherapy, announces that its Marketing Authorization Application (MAA) for BARHEMSYS® (amisulpride injection) has been submitted, validated and is now under formal review in major European markets. The review process is expected to be completed by Q3/2022. BARHEMSYS was approved in February 2020 by the Food and Drug Administration (FDA) for use in the United States...

Firm is the first to give investors access 25 crypto ETPs in Switzerland Zurich, September 28, 2021 – 21Shares AG (“21Shares”), the world’s largest issuer of cryptocurrency ETPs, today announced the listing of two additional cryptocurrency ETPs for a total of 25 listings on the leading Swiss exchange SIX. The new crypto index 21Shares Crypto Basket Equal Weight ETP (Ticker: HODLV) and 21Shares Crypto Basket 10 ETP (Ticker: HODLX). Jane Street will provide seed capital and serve as authorized participant for these two products. These ETPs emphasize 21Shares’ leadership in crypto ETP innovation and its research-driven product development approach:21Shares Crypto Basket Equal Weight ETP (HODLV) is a rules-based passive ETP based on the Vinter 21Shares “HODLV Index”. The HODLV Index tracks the top five eligible crypto assets, all weighted...

ASML provides strategy and financial update at virtual Investor Day meeting ASML increases long-term outlook VELDHOVEN, the Netherlands, September 29, 2021 – At the Investor Day meeting today, webcast live from its headquarters in Veldhoven, the Netherlands, ASML Holding N.V. (ASML) will provide an update on the company’s strategy, performance and long-term outlook. Chief Executive Officer Peter Wennink, together with Chief Technology Officer Martin van den Brink and Chief Financial Officer Roger Dassen and other senior executives, will discuss the company’s growth opportunities and developments in the market and technology. Company strategy, long-term outlook and value creationGlobal megatrends in the electronics industry, supported by a highly profitable and fiercely innovative ecosystem, are expected to continue to fuel growth...

September 29, 2021: Oslo, Norway, PGS on behalf of the PGS-TGS joint venture acquired over 10 000 sq.km of 3D GeoStreamer data offshore Newfoundland and Labrador between May and September this year. Fast-track results will be delivered in December 2021 and final imaging products will be ready Q1 2022.  The data from this year’s program expands the footprint of the PGS-TGS joint venture offshore Newfoundland and Labrador to approximately 80 000 sq. km. The focus of our 2021 acquisition was on the Cape Anguille survey in the Orphan Basin, with strategic additional acquisition on Lewis Hills and Jeanne d’Arc, Marine seismic acquisition on these project areas was carried out by the Ramform Atlas and Ramform Titan, in compliance with strict Covid-19 guidelines.  “We are very pleased the PGS-TGS joint venture has completed the 11th consecutive...